ArticleMolecular biology reports2025
First report of PDCD10 somatic mutation in liver cavernous malformation.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLiver cavernous malformation (CM) is a slow-flow venous malformation in which involved vessels appear tortuous and enlarged, often surrounded by a dense collagenous matrix. Endothelial cells (ECs) of affected vessels show disorganized junctions. Diagnosis usually occurs by computed tomography. Cavernous vessels are also observed in cerebral cavernous malformation (CCM), a disease affecting brain vasculature and occurring following mutations in KRIT1, CCM2 and PDCD10. Coexistence of brain and extra-neurological lesions has been reported. In this study, for the first time, we describe the possible common molecular basis between liver and brain cavernous lesions. METHODS AND
resultsGenotyping of the three CCM genes was performed on DNA purified from CM ECs. Comparison with DNA purified from control liver ECs allowed to identify several germline variants linked to CCM development. However, a novel PDCD10 rearrangement was uniquely detected in CM ECs. By TOPO-TA Cloning Sequencing, this rearrangement was characterized as an unbalanced translocation, der(7)t(3;7)(q26.1;p12.1). The translocation spans the FAT-homology domain of the PDCD10 protein, crucial for CCM2 binding and the formation of the CCM signalling complex.
conclusionsIdentification of the PDCD10 somatic mutation suggests a possible common pathogenesis for liver and brain cavernous lesions and allows to increase knowledge on the pathogenesis of liver vascular malformation. Further, for the first time the role of PDCD10 in extra-neurological cavernous lesions was reported.
Indexed as
Identifiers
40445461What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.